Medical Research
(H900)
990 on File
REGENSTRIEF FOUNDATION INC
Financial strength (30%)
92/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$14.9M
Total Revenue
$11.2M
Total Expenses
$139.9M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
76.4%
Fundraising Efficiency
N/A
Operating Reserve
149.64x
Liability-to-Asset
1.2%
Revenue Diversification
84.9%
Executive Compensation
$468K
Compared with Peers
FY 2025
Compared with 46 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
76.4% | 81.5% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
149.6 mo | 18.6 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
1.2% | 22.3% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
84.9% | 84.5% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
92.2% | 7.3% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
6.9% | 5.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
24.7% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $14.9M | $11.2M | $139.9M | 76.4% | — |
| 2024 | $7.7M | $10.5M | $136.2M | 76.3% | — |
| 2023 | $-258,456 | $12.5M | $139.0M | 78.3% | — |
| 2022 | $9.7M | $12.6M | $152.1M | 78.2% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.